Evaluation of Clinical Outcomes and Costs Based on Prescribed Dose Level of Renin-Angiotensin-Aldost

---

Evaluation of Clinical Outcomes and Costs Based on Prescribed Dose Level of Renin-Angiotensin-Aldosterone System Inhibitors

Murray Epstein, MD;Paula J. Alvarez, RPh, MPH, MBA;Nancy L. Reaven, MA;Susan E. Funk, MBA, FACHE;Karen J. McGaughey, PhD;Melanie S. Brenner, PharmD, BCPS;Wade Benton, PharmD;Ladan Golestane

August 31st 2016

ArticleARTICLES

---

eAppendix

August 31st 2016

ArticleEAPPENDIX

---

Participating Faculty

August 31st 2016

ArticleAUTHOR INDEX